CIRM doesn't want an active scientist president

Shortly after posting my linkurl:news story;http://www.the-scientist.com/news/home/53480/ on incoming linkurl:California Institute for Regenerative Medicine;http://www.the-scientist.com/article/display/22768/ interim president Richard Murphy, Robert Klein--chairman of CIRM's governing board--told me that a policy regarding candidates for the permanent position has recently been enacted. Klein said that through discussions in June and July, the board confirmed a policy that precluded candidates

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Shortly after posting my linkurl:news story;http://www.the-scientist.com/news/home/53480/ on incoming linkurl:California Institute for Regenerative Medicine;http://www.the-scientist.com/article/display/22768/ interim president Richard Murphy, Robert Klein--chairman of CIRM's governing board--told me that a policy regarding candidates for the permanent position has recently been enacted. Klein said that through discussions in June and July, the board confirmed a policy that precluded candidates who wish to maintain active labs during their term as CIRM president. Previously, such candidates were considered for the permanent position. "The most important issue is making certain we're maintaining the highest standard of objective scientific judgment without bias," Klein said. Klein explained that the policy avoids potential conflicts of interest that might arise with a president who also maintains a California-based lab that would be competing for linkurl:CIRM funding;http://www.the-scientist.com/blog/display/52856/ . Additionally, Klein said that the board wants a president who will be able to devote his or her complete attention to the job. "We're looking for this individual to be a leader of stem cell strategy in California, in the nation, and globally," he said. "In order to reach that level of leadership, it's a full-time job."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio